TY - JOUR
T1 - Brainstem encephalitis
T2 - Etiologies, treatment, and predictors of outcome
AU - Tan, Ik Lin
AU - Mowry, Ellen M.
AU - Steele, Sonya U.
AU - Pardo, Carlos A.
AU - McArthur, Justin C.
AU - Nath, Avindra
AU - Venkatesan, Arun
N1 - Funding Information:
Financial disclosure: Ellen M. Mowry: Funding NIH K23NS067055; National MS Society RG4407A2. Receipt of free study medication from Teva Neurological. Justin C. McArthur: Grants from NIH, Biogen-Idec, payment from lectures, speakers’ bureau in various universities, book royalties, stock option from Gliamed. Avindra Nath: Consultant to Biogen Idec and Diogenix. Arun Venkatesan: Grants from NIH, HHMI, Maryland Stem Cell Research Foundation, National Multiple Sclerosis Society. Ik Lin Tan, Sonya Steele, Carlos Pardo-Villamizar report no financial disclosure.
PY - 2013/9
Y1 - 2013/9
N2 - Brainstem encephalitis (BE) is an uncommon condition. We sought to characterize clinical presentations, etiologies, response to treatment, and predictors of outcome. We performed a retrospective review of non-HIV infected patients diagnosed with BE at Johns Hopkins Hospital (January 1997-April 2010). We characterized clinical and paraclinical features, and used regression models to assess associations with poor outcome. BE was diagnosed in 81 patients. An etiology was identified in 58 of 81 (71.6 %) of cases, most of which were confirmed or probable inflammatory/autoimmune conditions. Of the remaining 23 cases in which a specific diagnosis remained undefined, clinical presentation, CSF, neuroimaging studies, and outcomes were similar to the inflammatory/ autoimmune group. Brain biopsy identified a specific diagnosis in 7 of 14 patients (50 %). Fifteen patients (18.5 %) either died or had a poor outcome. In multivariate logistic regression models, a higher CSF protein (per 5 mg/dl, OR = 1.11, 95 % CI: 1.03-1.20), a higher CSF glucose (per 5 mg/dl, OR = 1.36, 95 % CI: 1.09-1.70), and higher serum glucose (per 5 mg/dl, OR = 1.27, 95 % CI: 1.06-1.52) were independently associated with increased odds of poor outcome. Inflammatory and non-infectious conditions accounted for most cases of BE. Higher CSF protein and glucose were independently associated with poor outcome. In immunocompetent patients with BE of undefined etiology despite extensive investigation, a trial of immunosuppressive treatment may be warranted, though deterioration clinically or on magnetic resonance imaging should prompt a brain biopsy.
AB - Brainstem encephalitis (BE) is an uncommon condition. We sought to characterize clinical presentations, etiologies, response to treatment, and predictors of outcome. We performed a retrospective review of non-HIV infected patients diagnosed with BE at Johns Hopkins Hospital (January 1997-April 2010). We characterized clinical and paraclinical features, and used regression models to assess associations with poor outcome. BE was diagnosed in 81 patients. An etiology was identified in 58 of 81 (71.6 %) of cases, most of which were confirmed or probable inflammatory/autoimmune conditions. Of the remaining 23 cases in which a specific diagnosis remained undefined, clinical presentation, CSF, neuroimaging studies, and outcomes were similar to the inflammatory/ autoimmune group. Brain biopsy identified a specific diagnosis in 7 of 14 patients (50 %). Fifteen patients (18.5 %) either died or had a poor outcome. In multivariate logistic regression models, a higher CSF protein (per 5 mg/dl, OR = 1.11, 95 % CI: 1.03-1.20), a higher CSF glucose (per 5 mg/dl, OR = 1.36, 95 % CI: 1.09-1.70), and higher serum glucose (per 5 mg/dl, OR = 1.27, 95 % CI: 1.06-1.52) were independently associated with increased odds of poor outcome. Inflammatory and non-infectious conditions accounted for most cases of BE. Higher CSF protein and glucose were independently associated with poor outcome. In immunocompetent patients with BE of undefined etiology despite extensive investigation, a trial of immunosuppressive treatment may be warranted, though deterioration clinically or on magnetic resonance imaging should prompt a brain biopsy.
KW - Autoimmune
KW - Brain biopsy
KW - Brainstem encephalitis
KW - Glucose
KW - Inflammatory
KW - Rhombencephalitis
UR - http://www.scopus.com/inward/record.url?scp=84884349954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884349954&partnerID=8YFLogxK
U2 - 10.1007/s00415-013-6986-z
DO - 10.1007/s00415-013-6986-z
M3 - Article
C2 - 23749332
AN - SCOPUS:84884349954
SN - 0340-5354
VL - 260
SP - 2312
EP - 2319
JO - Journal of neurology
JF - Journal of neurology
IS - 9
ER -